Page last updated: 2024-10-17

aminocaproic acid and Leukemia L5178

aminocaproic acid has been researched along with Leukemia L5178 in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Leukemia L5178: An experimental lymphocytic leukemia of mice.

Research Excerpts

ExcerptRelevanceReference
" The LD50 tests were made in rats and mice using both compounds."1.28Antitumor effect and toxicity of two new active-site-directed irreversible ornithine decarboxylase and extrahepatic arginase inhibitors. ( Joseph-Nathan, P; Koizumi, G; Muñoz, O; Trujillo-Ferrara, J; Yañez, R, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trujillo-Ferrara, J1
Koizumi, G1
Muñoz, O1
Joseph-Nathan, P1
Yañez, R1

Other Studies

1 other study available for aminocaproic acid and Leukemia L5178

ArticleYear
Antitumor effect and toxicity of two new active-site-directed irreversible ornithine decarboxylase and extrahepatic arginase inhibitors.
    Cancer letters, 1992, Dec-24, Volume: 67, Issue:2-3

    Topics: Amino Acids; Aminocaproates; Aminocaproic Acid; Animals; Antineoplastic Agents; Arginase; Drug Scree

1992